BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17635151)

  • 1. Bax-inhibiting peptides derived from Ku70 and cell-penetrating pentapeptides.
    Gomez JA; Gama V; Yoshida T; Sun W; Hayes P; Leskov K; Boothman D; Matsuyama S
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):797-801. PubMed ID: 17635151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-penetrating penta-peptides and Bax-inhibiting peptides: protocol for their application.
    Gomez J; Matsuyama S
    Methods Mol Biol; 2011; 683():465-71. PubMed ID: 21053150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bax-inhibiting peptide derived from mouse and rat Ku70.
    Yoshida T; Tomioka I; Nagahara T; Holyst T; Sawada M; Hayes P; Gama V; Okuno M; Chen Y; Abe Y; Kanouchi T; Sasada H; Wang D; Yokota T; Sato E; Matsuyama S
    Biochem Biophys Res Commun; 2004 Sep; 321(4):961-6. PubMed ID: 15358121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bax-inhibiting peptide protects cells from polyglutamine toxicity caused by Ku70 acetylation.
    Li Y; Yokota T; Gama V; Yoshida T; Gomez JA; Ishikawa K; Sasaguri H; Cohen HY; Sinclair DA; Mizusawa H; Matsuyama S
    Cell Death Differ; 2007 Dec; 14(12):2058-67. PubMed ID: 17885668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Penetrating Penta-Peptides (CPP5s): Measurement of Cell Entry and Protein-Transduction Activity.
    Gomez JA; Chen J; Ngo J; Hajkova D; Yeh IJ; Gama V; Miyagi M; Matsuyama S
    Pharmaceuticals (Basel); 2010 Dec; 3(12):3594-3613. PubMed ID: 21359136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70.
    Sawada M; Hayes P; Matsuyama S
    Nat Cell Biol; 2003 Apr; 5(4):352-7. PubMed ID: 12652309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it.
    Rashmi R; Kumar S; Karunagaran D
    Carcinogenesis; 2004 Oct; 25(10):1867-77. PubMed ID: 15205359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bax-inhibiting peptide protects glutamate-induced cerebellar granule cell death by blocking Bax translocation.
    Iriyama T; Kamei Y; Kozuma S; Taketani Y
    Neurosci Lett; 2009 Feb; 451(1):11-5. PubMed ID: 19110033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maspin increases Ku70 acetylation and Bax-mediated cell death in cancer cells.
    Lee SJ; Jang H; Park C
    Int J Mol Med; 2012 Feb; 29(2):225-30. PubMed ID: 22076034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors.
    Subramanian C; Opipari AW; Bian X; Castle VP; Kwok RP
    Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4842-7. PubMed ID: 15778293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics simulation and automated docking of the pro-apoptotic Bax protein and its complex with a peptide designed from the Bax-binding domain of anti-apoptotic Ku70.
    Mancinelli F; Caraglia M; Budillon A; Abbruzzese A; Bismuto E
    J Cell Biochem; 2006 Sep; 99(1):305-18. PubMed ID: 16619258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of a cyclin E fragment with Ku70 regulates Bax-mediated apoptosis.
    Mazumder S; Plesca D; Kinter M; Almasan A
    Mol Cell Biol; 2007 May; 27(9):3511-20. PubMed ID: 17325036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bax deficiency extends the survival of Ku70 knockout mice that develop lung and heart diseases.
    Ngo J; Matsuyama M; Kim C; Poventud-Fuentes I; Bates A; Siedlak SL; Lee HG; Doughman YQ; Watanabe M; Liner A; Hoit B; Voelkel N; Gerson S; Hasty P; Matsuyama S
    Cell Death Dis; 2015 Mar; 6(3):e1706. PubMed ID: 25811803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NBS1 regulates a novel apoptotic pathway through Bax activation.
    Iijima K; Muranaka C; Kobayashi J; Sakamoto S; Komatsu K; Matsuura S; Kubota N; Tauchi H
    DNA Repair (Amst); 2008 Oct; 7(10):1705-16. PubMed ID: 18644472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of caveolin-1 with Ku70 inhibits Bax-mediated apoptosis.
    Zou H; Volonte D; Galbiati F
    PLoS One; 2012; 7(6):e39379. PubMed ID: 22745744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-treatment of Bax-inhibiting peptide reduces neuronal death and behavioral deficits following global cerebral ischemia.
    Han B; Wang Q; Cui G; Shen X; Zhu Z
    Neurochem Int; 2011 Feb; 58(2):224-33. PubMed ID: 21167243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the proapoptotic factor Bax by Ku70-dependent deubiquitylation.
    Amsel AD; Rathaus M; Kronman N; Cohen HY
    Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5117-22. PubMed ID: 18362350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Going Ku Ku on Bax.
    Beckman M
    Sci Aging Knowledge Environ; 2004 Mar; 2004(11):nf31. PubMed ID: 15028862
    [No Abstract]   [Full Text] [Related]  

  • 19. Ku70 suppresses the apoptotic translocation of Bax to mitochondria.
    Sawada M; Sun W; Hayes P; Leskov K; Boothman DA; Matsuyama S
    Nat Cell Biol; 2003 Apr; 5(4):320-9. PubMed ID: 12652308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of Bax-induced cell death: Bax-inhibiting peptides and small compounds inhibiting Bax.
    Jensen K; WuWong DJ; Wong S; Matsuyama M; Matsuyama S
    Exp Biol Med (Maywood); 2019 May; 244(8):621-629. PubMed ID: 30836793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.